KRAS and colorectal carcinoma: For example, the aberrant activation of the RAF/MEK/ERK pathway by mutant KRAS leads to the upregulation of insulin-like growth factor-I receptor (IGF-IR), thus promoting CRC metastasis to the liver [14].